Page last updated: 2024-10-24

pyrimidine-containing compound transmembrane transport

Definition

Target type: biologicalprocess

The process in which a pyrimidine-containing compound is transported across a membrane. A pyrimidine-containing compound is any compound that contains pyrimidine or a formal derivative thereof. [GOC:mah]

Pyrimidine-containing compound transmembrane transport is a crucial biological process that enables the movement of pyrimidine bases, such as cytosine, thymine, and uracil, across cell membranes. These bases are essential building blocks for nucleic acids (DNA and RNA), which play vital roles in genetic information storage, transmission, and protein synthesis. The transport process is highly regulated and involves specialized membrane proteins known as pyrimidine transporters. These proteins facilitate the passage of pyrimidines across the cell membrane, ensuring the appropriate levels of these essential molecules within the cell.

The process typically involves the following steps:

1. **Binding of pyrimidine:** Pyrimidine molecules bind to specific sites on the transporter protein, initiating the transport process. The binding event can be influenced by factors such as the concentration gradient of the pyrimidine across the membrane, the pH of the environment, and the presence of other molecules that might compete for binding sites.
2. **Conformational change:** Upon binding, the transporter protein undergoes a conformational change, altering its structure to allow passage of the pyrimidine across the membrane. This change can be triggered by various mechanisms, including phosphorylation, binding of cofactors, or changes in membrane potential.
3. **Translocation of pyrimidine:** The pyrimidine molecule moves across the membrane through a channel or pore created by the transporter protein. This movement is driven by the concentration gradient of the pyrimidine, the electrical potential difference across the membrane, or the energy provided by ATP hydrolysis.
4. **Release of pyrimidine:** Once the pyrimidine molecule reaches the other side of the membrane, it dissociates from the transporter protein, completing the transport cycle.

The process of pyrimidine-containing compound transmembrane transport is essential for maintaining cellular function and is tightly regulated by a variety of mechanisms. Disruptions in this process can lead to various diseases, including cancer and genetic disorders. For instance, mutations in pyrimidine transporter genes can lead to deficiencies in pyrimidine metabolism, causing severe neurological defects.

Furthermore, this process is targeted by certain drugs used in cancer treatment. Some drugs inhibit the activity of pyrimidine transporters, thereby blocking the uptake of pyrimidines into cancer cells, leading to their growth inhibition.

Overall, the complex and tightly regulated process of pyrimidine-containing compound transmembrane transport is essential for maintaining cellular homeostasis and is of great significance in various biological processes, including nucleic acid synthesis and disease development.'
"

Proteins (5)

ProteinDefinitionTaxonomy
Solute carrier family 28 member 3A solute carrier family 28 member 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9HAS3]Homo sapiens (human)
Equilibrative nucleoside transporter 1An equilibrative nucleoside transporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q99808]Homo sapiens (human)
Equilibrative nucleoside transporter 2An equilibrative nucleoside transporter 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q14542]Homo sapiens (human)
Sodium/nucleoside cotransporter 2A sodium/nucleoside cotransporter 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O43868]Homo sapiens (human)
Sodium/nucleoside cotransporter 1A sodium/nucleoside cotransporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O00337]Homo sapiens (human)

Compounds (26)

CompoundDefinitionClassesRoles
dilazepdilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.

Dilazep: Coronary vasodilator with some antiarrhythmic activity.
benzoate ester;
diazepane;
diester;
methoxybenzenes
cardioprotective agent;
platelet aggregation inhibitor;
vasodilator agent
dipyridamoledipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
piperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol
adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
lidoflazineLidoflazine: Coronary vasodilator with some antiarrhythmic action.diarylmethane
phloretindihydrochalconesantineoplastic agent;
plant metabolite
floxuridinefloxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
nucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
radiosensitizing agent
uridineuridinesdrug metabolite;
fundamental metabolite;
human metabolite
phlorhizinaryl beta-D-glucoside;
dihydrochalcones;
monosaccharide derivative
antioxidant;
plant metabolite
resacetophenone2',4'-dihydroxyacetophenone : A dihydroxyacetophenone that is acetophenone carrying hydroxy substituents at positions 2' and 4'.

resacetophenone: structure in first source
dihydroxyacetophenone;
resorcinols
plant metabolite
methylthioinosineMethylthioinosine: 6-(Methylthio)-9-beta-D-ribofuranosylpurine. An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position.purine ribonucleoside;
thiopurine
hyaluronoglucosaminidasekinetin riboside: preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells; structure in first sourcepurine nucleoside
gemcitabinegemcitabine : A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer.organofluorine compound;
pyrimidine 2'-deoxyribonucleoside
antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
draflazinedraflazine: a nucleoside transport inhibitor; has cardioprotective effect; draflazine is the (-)-enantiomer; R 88016 is the (+)-enantiomer
adenosinequinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlitadenosines;
purines D-ribonucleoside
analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
4-nitrobenzylthioinosine4-nitrobenzylthioinosine: inhibitor of nucleoside transport; acts on ENT1purine nucleoside
2,4,6-trihydroxyacetophenone2',4',6'-trihydroxyacetophenone : A benzenetriol that is acetophenone in which the hydrogens at positions 2, 4, and 6 on the phenyl group are replaced by hydroxy groups. It is used as a matrix in matrix-assisted laser desorption/ionization (MALDI) mass spectrometry for the analysis of acidic glycans and glycopeptides.

monoacetylphloroglucinol: structure in first source
aromatic ketone;
benzenetriol;
methyl ketone
MALDI matrix material;
plant metabolite
2,6-dihydroxyacetophenone2,6-dihydroxyacetophenone: inhibits aminopyrine-N-demethylase in rat liver microsomal preparationsaromatic ketone
n(6)-benzyladenosineN(6)-benzyladenosine: RN given refers to parent cpd
6-(4-nitrobenzylthio)guanosine6-(4-nitrobenzylthio)guanosine: inhibitor of nucleoside transport
5-iodotubercidin7-iodotubercidin: inhibits Toxoplasma gondii adenosine kinaseorganoiodine compound
n(6)-phenyladenosinepurine nucleoside
tecadenosontecadenoson: an A1 adenosine receptor agonist
2-hydroxy-5-nitrobenzylthioguanosine
n(6)-cyclopentyladenosine
7,8,3'-trihydroxyflavone7,8,3'-trihydroxyflavone: a potent small molecule TrkB receptor agonist that protects spiral ganglion neurons from degeneration both in vitro and in vivo
trilobatintrilobatin : An aryl beta-D-glucoside that is phloretin attached to a beta-D-glucopyranosyl residue at position 4' via a glycosidic linkage. It is isolated from the leaves of the Chinese sweet tea Lithocarpus polystachyus and exhibits significant anti-hyperglycemic, anti-oxidative and anti-inflammatory properties.

trilobatin: anti-inflammatory from Lithocarpus polystachyus leaves; structure in first source
aryl beta-D-glucoside;
dihydrochalcones;
monosaccharide derivative
anti-inflammatory agent;
antioxidant;
plant metabolite;
sweetening agent
6-benzylthioinosine6-benzylthioinosine: a subversive substrate of T gondii adenosine kinase; structure in first source